← Eichor
Study identifier: NCT07166302 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

Condition: Direct Acting Anticoagulant Adverse Reaction · Needle Injury · EMG  ·  Sponsor: Masaryk University

PhaseN/A
Planned participants70
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG. The aim of the study is to determine whether needle EMG can be considered a safe procedure in this group of patients, without posing a risk of intramuscular hematoma formation.

This description comes directly from the study's public registry record.

Talk to the study team

Adam Betík, MD  ·  +420532232503  ·  betik.adam@fnbrno.cz

Eva Vlckova, MD  ·  +420532233221  ·  vlckova.eva@fnbrno.cz

Always discuss trial participation with your own doctor first.

Locations (2)

University Hospital BrnoBrno, Czech Republic, CzechiaRecruiting
University hospital BrnoBrno, Czech Republic, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07166302